Capital Flow Monitor · Sponsors · CIK 1645892
Sonavex, Inc.
2835 O'DONNELL STREET, BALTIMORE, MD, 21224 · 443.862.2024
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$15.0M
Sold
$3.1M
% sold
20.7%
Investors
5
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-28 | D ·current | 506(b) | $15.0M | $3.1M | 20.7% | 5 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
David Narrow — Executive Officer / Director, Baltimore, MD
1 other raise
- Cultivation Capital Life Sciences Fund IV, LP $6.5M of $40.0M · 16.3%
- Devin O'Brien-Coon — Director, Baltimore, MD
- Alex Yevzlin — Executive Officer, Baltimore, MD
- William Niland — Director, Baltimore, MD
- Robert Hallenbeck — Director, Baltimore, MD
-
Evan Pritchard — Director, Baltimore, MD
3 other raises
- JStar Capital Investments VII, LLC $7.6M of $7.6M · 100.0%
- JSTAR Horizon Fund II-A, LP $2.6M of —
- JSTAR HORiZON FUND II LP $22.0M of $100.0M · 22.0%
- Michael J. Hennessy, Jr. — Director, Baltimore, MD
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.